摘要
目的:探讨乙肝病毒DNA(HBV-DNA)与其血清学标志物HBV-M之间的相关性。方法:选取本院收治的乙肝患者183例作为研究对象,采集并分离患者的血清标本,分别采用荧光定量PCR法和酶联免疫吸附法对患者的HBV-DNA、HBV-M进行检测,在不同的HBV-M模式下分析其与HBV-DNA间的关系。结果:在HBsAg(+)+HBeAg(+)+HBcAb(+)的模式下,HBV-DNA的检测阳性率为97.9%;HBsAg(+)+HBeAg(+)模式下,HBV-DNA的检测阳性率是100%;两者比较差异无统计学意义,但这两种模式下的检测阳性率都显著高于其他模式(P<0.05)。结论:乙肝病毒的血清学标志物的模式不同,HBV-DNA的检测阳性率不同,乙肝患者机体内的病毒含量也有差异,HBV-M和HBV-DNA的检测分别是乙肝感染的间接证据和直接证据,同时对患者进行这两项指标的检测对于乙肝的临床诊断、病情判定、传染性的评估具有重要的意义。
Objective:To discuss the correlation between hepatitis B virus DNA and HBV-M.Method: Five hundred and forty-nine hepatitis B patients were selected in our hospital. Patients’ serum samples were collected, its HBV-DNA and HBV-M were detected by using quantitative PCR and enzyme-linked immunosorbent assay. The correlative between HBV-M and HBV-DNA was analyzed.Result: In HBsAg (+) + HBeAg (+) + HBcAb (+) mode, the positive rate of HBV-DNA was 97.9%. In HBsAg (+) + HBeAg (+) mode, the positive rate of HBV-DNA was 100%. The positive rates were not seen significant difference between the two modes, but they were significantly higher than the other modes(P〈0.05).Conclusion: There are some correlations between serological markers of hepatitis B virus and HBV-DNA. HBV-M and HBV-DNA testing are circumstantial evidence and direct evidence of hepatitis B infection, while these two indicators of patient clinical diagnostic testing for hepatitis B, the condition determination, infectious assessment are of great significance.
出处
《中国医学创新》
CAS
2014年第25期123-124,共2页
Medical Innovation of China